Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
US: FDA approval not reviewed here
The registry reports active not recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 3 · Ongoing, no longer enrolling
Planned enrollment: 250 participants
Study ages: 18 Years to 99 Years
No results-posting date in this record
Read trial record and resultsChecked Nov 17, 2026